Literature DB >> 7380474

Hapten-cell conjugates in DNCB contact sensitivity. In vitro stimulation with DNP-conjugates optimally inducing contact sensitivity in vivo.

M von Blomberg, R J Scheper.   

Abstract

Until now in vitro stimulation tests have failed to detect DNCB contact sensitivity in guinea-pigs sensitized epicutaneously without the use of adjuvants. In this study DNP-conjugates optimally inducing contact sensitivity in vivo were tested for their capacity to detect DNCB contact sensitivity in vitro in a lymphocyte transformation assay. In vivo contact sensitivity measurements in guinea-pigs which had been immunized with different hapten-cell conjugates, showed that (1) living cells should be used for conjugation with the allergen, (2) macrophages are optimal carriers and (3) syngeneity is not required. Therefore, DNFB-coated peritoneal macrophages (viable when conjugated) were used as an antigen for in vitro stimulation. Using this conjugate, a highly reproducible antigen-specific increase in DNA synthesis could be obtained in lymph node lymphocytes from guinea-pigs that had been sensitized to DNCB by epicutaneous application of the allergen without the use of adjuvants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380474      PMCID: PMC1457957     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Contact sensitivity in vitro. The production of macrophage inhibition factors from DNCB sensitized lymphocytes by subcellular organelles obtained from DNCB epidermal tissue.

Authors:  K Nishioka; H E Amos
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

2.  In vitro sensitisation to dinitrochlorobenzene in guinea pigs.

Authors:  L Polak; E Macher
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Rosette-forming cells and the immunological response after DNCB, DNP-carrier and oxazolone sensitization.

Authors:  R J Scheper; J Oort
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

4.  A comparison of the effect of anti-lymph node serum and anti-granulocyte serum on local passive transfer of the tuberculin reaction and the normal lymphocyte transfer reaction.

Authors:  J L Turk; L Polák
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

5.  Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig.

Authors:  D Parker; J L Turk
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

6.  Lymphocyte transformation in contact sensitivity.

Authors:  A F Geczy; A Baumgarten
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

7.  Induction of delayed hypersensitivity by dinitrophenylated lymphocytes.

Authors:  A Baumgarten; A F Geczy
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

8.  In vitro lymphocyte responses in contact hypersensitivity. II.

Authors:  J E Milner
Journal:  J Invest Dermatol       Date:  1971-05       Impact factor: 8.551

9.  Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man.

Authors:  A E Miller; W R Levis
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na).

Authors:  P Phanuphak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

View more
  2 in total

1.  Characterization of lymphocyte subpopulations which exhibit enhanced DNA synthesis in vitro in DNFB contact sensitive guinea-pigs.

Authors:  R J Scheper; L Polak
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

2.  Influence of anti-inflammatory drugs on the interaction of lymphocytes and macrophages.

Authors:  H Mullink; M von Blomberg
Journal:  Agents Actions       Date:  1980-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.